EXPERT OPINION ON BIOLOGICAL THERAPY, published by Taylor & Francis Ltd, is a prestigious journal that has been a cornerstone in the fields of Clinical Biochemistry, Drug Discovery, and Pharmacology since its inception in 2001. With an impressive impact factor reflecting Q1 status across its categories in 2023, this journal is ranked among the top in both the pharmacology and biochemistry domains, featuring in the 81st and 77th percentiles respectively. This makes it an essential resource for researchers, professionals, and students who are keen on staying at the forefront of biological therapy advancements. The journal encompasses a broad yet focused scope, providing valuable insights into innovative therapeutic strategies and drug development methodologies. Researchers benefit from the rigorous peer-review process and the opportunity to disseminate their findings to a global audience, without the constraints of open access, ensuring the integrity and prestige of published work. As it converges towards 2024, EXPERT OPINION ON BIOLOGICAL THERAPY remains an influential platform for fostering collaboration and discussion in the evolutionary landscape of biological therapies.

Optica Pura y Aplicada, published by the SOC ESPANOLA OPTICA, stands as a vital platform for the dissemination of cutting-edge research in the fields of Atomic and Molecular Physics, Optics, and related engineering disciplines. Established in Spain, this journal aims to foster the advancement of knowledge in optical science and technology by providing a rigorous peer-reviewed publication outlet for scholars, researchers, and practitioners. Despite being categorized in the Q4 quartile across multiple domains, including Engineering and Materials Science, the journal remains committed to contributing meaningful insights and advancements within its scope. With an ISSN of 0030-3917 and an E-ISSN of 2171-8814, the journal effectively reaches a global audience eager to explore innovative applications and theoretical developments in optics and materials science. Researchers and professionals alike will find in Optica Pura y Aplicada a valuable resource for enriching their understanding and practices in an ever-evolving field, fostering collaborations and promoting research growth until its converged conclusion in 2024.

Expert Review of Anti-Infective Therapy, published by Taylor & Francis Ltd, is a leading journal in the field of infectious diseases, microbiology, and virology, boasting an impressive impact factor and ranking in the Q1 category across multiple disciplines. With an ISSN of 1478-7210 and E-ISSN 1744-8336, this journal has become a vital resource for researchers, professionals, and students aiming to advance their understanding of anti-infective therapies. Since its inception in 2003, the journal has provided critical insights, evidence-based reviews, and forward-thinking perspectives that contribute significantly to the ongoing efforts in combating infectious diseases. As of 2023, it ranks #36 out of 344 in Medicine/Infectious Diseases and maintains high percentiles in various other categories, reflecting its influence and reach within the scientific community. Although not an Open Access journal, its rich content is delivered through various academic libraries, sustaining its commitment to disseminating knowledge in the face of global health challenges. For those committed to innovation in the field, the Expert Review of Anti-Infective Therapy offers a platform that blends thorough research with practical applications, making significant strides in the fight against infectious pathogens.

The JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY C-PHOTOCHEMISTRY REVIEWS, published by Elsevier, is a premier scholarly journal that serves as a critical resource for researchers and professionals in the field of photochemistry and photobiology. With a distinguished Q1 ranking in key categories such as Catalysis, Organic Chemistry, and Physical and Theoretical Chemistry, this journal consistently publishes high-impact articles that contribute significantly to the advancement of knowledge in these disciplines. The journal's rigorous peer-review process ensures the integrity and quality of the research it disseminates. Researchers benefit from its comprehensive review articles that discuss recent advancements, theoretical developments, and practical applications of photochemical processes, making it an essential read for anyone in the field. The journal's impact and relevance are evidenced by its impressive Scopus rankings, including a top percentile of 98th in Organic Chemistry. As the journal continues to explore innovative and interdisciplinary approaches, it stands out as a vital platform for sharing and discussing cutting-edge research findings within the community.

Journal of Biophotonics is a prestigious academic journal published by WILEY-V C H VERLAG GMBH in Germany, dedicated to advancing the field of biophotonics through high-quality research. With an ISSN of 1864-063X and an E-ISSN of 1864-0648, this journal is recognized for its contributions within diverse categories, including biochemistry, genetics, molecular biology, chemistry, engineering, materials science, and physics, earning a commendable Q2 ranking in several of these fields as of 2023. The journal aims to bridge the gap between theoretical research and practical applications, fostering interdisciplinary collaboration that is critical for innovations in imaging, diagnostics, and therapeutics. Researchers, professionals, and students alike will find the Journal of Biophotonics invaluable for staying informed about the latest developments and breakthroughs in this dynamic field, making it a cornerstone for knowledge dissemination and scholarly discourse from its inception in 2008 and continuing through 2024.

Photochemistry and Photobiology is a premier journal published by Wiley, dedicated to advancing the field of photochemistry and its applications in biology. With a long-standing history since its inception in 1962, this journal is recognized for its significant contribution to the understanding of light-driven processes, encompassing areas such as biochemistry, medicine, and theoretical chemistry. As evidenced by its impressive Q2 rankings in several categories, including Biochemistry and Physical and Theoretical Chemistry, Photochemistry and Photobiology is an influential resource for researchers and professionals worldwide. The journal's commitment to high-quality research is reflected in its solid standing within important Scopus ranks, marking it as a vital outlet for innovative studies that elucidate the roles of photochemical reactions in biological systems. While it operates on a traditional model rather than Open Access, the journal remains a crucial platform for exchanging knowledge and fostering collaborations across these interconnected disciplines. Explore the latest findings and contribute to the growing body of knowledge in this dynamic field.

Cancer Treatment Reviews, published by Elsevier Science Ltd, is a leading international journal dedicated to the exploration and advancement of therapeutic strategies in oncology. With an impressive impact factor that reflects its status in the field, this journal is classified within Q1 quartile rankings in Medicine (Miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging, as of 2023. The journal has a rich lineage, having been established in 1974 and consistently evolving to encompass the latest breakthroughs and methodologies in cancer treatment. A vital resource for researchers, clinicians, and students alike, it aims to promote understanding and application of effective interventions, thereby contributing to improvements in patient outcomes. By prioritizing high-quality reviews, Cancer Treatment Reviews plays an essential role in bridging the gap between current research and clinical practice, making it an indispensable asset in the continuous fight against cancer.

Welcome to the Journal of Innovative Optical Health Sciences, an esteemed platform dedicated to the interdisciplinary exploration of optical technologies in health sciences. Published by World Scientific Publishing Co Pte Ltd, this open-access journal has been at the forefront of innovation since its inception in 2008, facilitating vital discussions and research advancements. With a notable impact factor and a commendable ranking in various scientific categories—including Q2 in Atomic and Molecular Physics, Q3 in Biomedical Engineering, and Q3 in Medicine (miscellaneous)—the journal serves as an essential resource for researchers, professionals, and students alike. Hailing from Singapore, we aim to bridge the gap between optical science and healthcare, promoting breakthroughs that enhance patient care and medical practices. Explore our diverse collection of studies and join a vibrant community committed to advancing knowledge in this cutting-edge field.

PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, published by WILEY, is a leading academic journal dedicated to the interdisciplinary study of skin-related health issues, particularly focusing on the impacts of ultraviolet light as well as the immunological and therapeutic aspects of photomedicine. With a rich publication history dating back to 1990 and a commitment to advancing knowledge in its field, this journal serves as a vital resource for researchers and professionals working in dermatology, immunology, and related disciplines. Recognized for its high impact, it has achieved a Q1 classification in Dermatology and holds robust rankings in several other categories, reflecting its strong contribution to scholarly discourse. Although it does not currently operate as an Open Access publication, PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE remains crucial for disseminating essential findings and innovations, particularly for those involved in studies exploring the intersections of skin health, immune response, and therapeutic technologies.

Expert Review of Anticancer Therapy, published by Taylor & Francis Ltd, is a distinguished journal focusing on the dynamic and ever-evolving field of oncology and pharmacology. Since its inception in 2001, this journal has played a pivotal role in disseminating critical reviews and analyses of novel anticancer therapies, fostering a deeper understanding among researchers and practitioners alike. With an impressive categorization in the 2023 Q2 quartiles for both Oncology and Pharmacology, it ranks #98 out of 272 in Pharmacology and #165 out of 404 in Oncology according to Scopus metrics, placing it well within the upper echelons of academic journals. The journal’s rigorous peer-review process ensures high-quality publications that are integral for advancing cancer research and therapeutic strategies. Although currently not an open access journal, it aims to bridge the gap between scientific discovery and clinical application, making it an essential resource for anyone involved in the fight against cancer.